GSK plc (LON:GSK)

Market Cap	73.27B
Revenue (ttm)	32.17B
Net Income (ttm)	5.49B
Shares Out	4.02B
EPS (ttm)	1.33
PE Ratio	13.72
Forward PE	10.21
Dividend	0.61 (3.34%)
Ex-Dividend Date	Nov 13, 2025

Volume	2,403,223
Average Volume	8,381,398
Open	1,811.50
Previous Close	1,823.50
Day's Range	1,793.94 - 1,817.50
52-Week Range	1,242.50 - 1,830.00
Beta	0.23
RSI	67.48
Earnings Date	Oct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 68,629
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.